[go: up one dir, main page]

AU4868096A - Polypeptides derived from urinastatin having calcium channel blocking activity and their use to delay premature delivery - Google Patents

Polypeptides derived from urinastatin having calcium channel blocking activity and their use to delay premature delivery

Info

Publication number
AU4868096A
AU4868096A AU48680/96A AU4868096A AU4868096A AU 4868096 A AU4868096 A AU 4868096A AU 48680/96 A AU48680/96 A AU 48680/96A AU 4868096 A AU4868096 A AU 4868096A AU 4868096 A AU4868096 A AU 4868096A
Authority
AU
Australia
Prior art keywords
urinastatin
calcium channel
blocking activity
channel blocking
polypeptides derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48680/96A
Inventor
David Casal
Naohiro Kanayama
Toshihiko Terao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adeza Biomedical Corp
Original Assignee
Adeza Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adeza Biomedical Corp filed Critical Adeza Biomedical Corp
Publication of AU4868096A publication Critical patent/AU4868096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU48680/96A 1995-02-23 1996-02-13 Polypeptides derived from urinastatin having calcium channel blocking activity and their use to delay premature delivery Abandoned AU4868096A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39431895A 1995-02-23 1995-02-23
US394318 1995-02-23
PCT/US1996/002018 WO1996026273A1 (en) 1995-02-23 1996-02-13 Polypeptides derived from urinastatin having calcium channel blocking activity and their use to delay premature delivery

Publications (1)

Publication Number Publication Date
AU4868096A true AU4868096A (en) 1996-09-11

Family

ID=23558430

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48680/96A Abandoned AU4868096A (en) 1995-02-23 1996-02-13 Polypeptides derived from urinastatin having calcium channel blocking activity and their use to delay premature delivery

Country Status (2)

Country Link
AU (1) AU4868096A (en)
WO (1) WO1996026273A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6678669B2 (en) 1996-02-09 2004-01-13 Adeza Biomedical Corporation Method for selecting medical and biochemical diagnostic tests using neural network-related applications
US6394952B1 (en) 1998-02-03 2002-05-28 Adeza Biomedical Corporation Point of care diagnostic systems
WO2020106881A1 (en) * 2018-11-20 2020-05-28 Diamedica Inc. Modified ulinastatin polypeptides
EP4114428A4 (en) 2020-03-05 2025-03-12 Diamedica USA Inc. ULINASTATIN POLYPEPTIDES
CN114525247A (en) * 2022-03-14 2022-05-24 吉林壹众生物科技有限公司 Method for improving yield of stem cell cytokines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0401508B1 (en) * 1989-05-13 1994-11-23 Bayer Ag Proteinaseinhibitors, method for their preparation and pharmaceutical compositions containing them
JPH0584083A (en) * 1990-11-13 1993-04-06 Mochida Pharmaceut Co Ltd New polypeptide, new dna coding the same polypeptide, production of new polypeptide, new medicine composition and new enzyme inhibiting method
US5451659A (en) * 1991-11-08 1995-09-19 Mochida Pharmaceutical Co., Ltd. Polypeptide, DNA fragment encoding the same, drug composition containing the same and process for producing the same
JPH05308988A (en) * 1992-05-12 1993-11-22 Mochida Pharmaceut Co Ltd Novel polypeptide, novel DNA, novel vector, novel transformant, novel pharmaceutical composition, and method for producing novel polypeptide
JP3570558B2 (en) * 1993-05-01 2004-09-29 持田製薬株式会社 DNA fragment, vector containing the same, transformant transformed with the vector, and method for producing protein using the vector
US5650394A (en) * 1993-11-04 1997-07-22 Adeza Biomedical Use of urinastatin-like compounds to prevent premature delivery

Also Published As

Publication number Publication date
WO1996026273A1 (en) 1996-08-29

Similar Documents

Publication Publication Date Title
AU692612B2 (en) Peptide mixture and products thereof
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU2075897A (en) Delivery system using mab 3e10 and mutants and/or functional fragments thereof
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU6124196A (en) Novel dolastatin derivatives, their preparation and use
AU7068896A (en) Protein composition derived from sesame seed and use thereof
AU7237496A (en) Methods and compositions comprising single chain recombinant antibodies
AU4266596A (en) Composition and use
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU5363596A (en) Biocompatible materials
AU5824998A (en) Apparatus for adjusting the forward lean and flexibility of footwear
AU6281599A (en) Alternate day administration of copolymer 1 for treating autoimmune diseases
AU1592299A (en) Skin rash prevention composition
AU2259897A (en) Methods and compositions for the simultaneous control of rootdiseases
AU1350797A (en) Artificial skin construction
IL112320A0 (en) Quinazoline-2,4- diones, their preparation and pharmaceutical compositions containing them
AU4628993A (en) Physiologically active peptide composition
AU6856896A (en) Reconstituted skin
AU4905497A (en) Antimicrobial peptide analogs of gramicidin s and compositions comprising them
AU3193097A (en) Il-6 and il-6-receptor derived peptides having il-6 antagonistic or agonistic activity
AU7000896A (en) Novel peptide compounds and medicinal compositions thereof
AU4868096A (en) Polypeptides derived from urinastatin having calcium channel blocking activity and their use to delay premature delivery
AU4636396A (en) Antiglucocorticoid medicament
AU4649293A (en) Angiotensin iv peptides and receptor
AU6591596A (en) Gene encoding the human homolog of mad2